Trial intelligence / Profile preview

Aricept in Dementia with Lewy Bodies

NCT02345213Phase 4Completed

Sponsor
Eisai Co., Ltd.
Start
Mar 2015
Primary completion
May 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of donepezil in dementia with Lewy bodies (DLB), sponsored by Eisai Co., Ltd.. Started Mar 2015; status: completed.

02

Drugs

donepezil
03

Conditions

dementia with Lewy bodies (DLB)

Beyond the preview

Go deeper on NCT02345213.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02345213.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call